000020 — Dongwha Pharm Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareConservativeSmall CapNeutral

Market Cap
KR₩163bn
Enterprise Value
KR₩279bn
Revenue
KR₩496bn

Annual balance sheet for Dongwha Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	R2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	119,210	100,875	87,234	43,494	24,339
Net Total Accounts Receivable
Net Total Receivables	61,094	69,814	74,368	100,515	90,999
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	220,199	227,527	237,700	237,806	217,615
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	142,851	151,153	188,330	219,546	210,056
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	447,804	461,136	558,520	619,635	642,168
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	66,461	75,562	106,134	134,011	202,826
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	100,870	96,736	186,741	246,264	262,641
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	346,935	364,400	371,780	373,371	379,527
Total Liabilities & Shareholders' Equity	447,804	461,136	558,520	619,635	642,168
Total Common Shares Outstanding